Search research articles
Contact Us
Filters
Showing results (101-110 of 154) with videos related to
Page
of 16
Sort By:
Pharmacogenomics and Personalized Medicine
|
March 17, 2021
Tackling Drug Resistance in EGFR Exon 20 Insertion Mutant Lung Cancer
Laura Pacini, Andrew D Jenks, Simon Vyse, et al.
Diabetes, Obesity & Metabolism
|
May 27, 2026
Randomised Controlled Feasibility Trial of Face-To-Face Diabetes Self-Management Education Shows High Completion Rates Are Needed to Improve Patient-Reported Outcomes
Gemma A Lewis, David M Hughes, Greg J Irving, et al.
Neuroendocrinology
|
April 1, 1993
Increases in neuropeptide Y content and gene expression in the hypothalamus of rats treated with dexamethasone are prevented by insulin
J P Wilding, S G Gilbey, P D Lambert, et al.
Journal of Neuroendocrinology
|
April 1, 1996
Reduced NPY induced feeding in diabetic but not steroid-treated rats: lack of evidence for changes in receptor number or affinity
D G Morgan, P D Lambert, D M Smith, et al.
Clinical Chemistry
|
November 9, 2000
Evaluation of DNA fragment sizing and quantification by the agilent 2100 bioanalyzer
N J Panaro, P K Yuen, T Sakazume, et al.
Brain Research
|
September 5, 1994
Effect of food deprivation and streptozotocin-induced diabetes on hypothalamic neuropeptide Y release as measured by a radioimmunoassay-linked microdialysis procedure
P D Lambert, J P Wilding, M D Turton, et al.
Brain Research
|
November 26, 1993
The effect of central blockade of kappa-opioid receptors on neuropeptide Y-induced feeding in the rat
P D Lambert, J P Wilding, A A al-Dokhayel, et al.
Journal of Diabetes and Its Complications
|
January 2, 2013
Active- and placebo-controlled dose-finding study to assess the efficacy, safety, and tolerability of multiple doses of ipragliflozin in patients with type 2 diabetes mellitus
Vivian A Fonseca, Ele Ferrannini, John P Wilding, et al.
QJM : Monthly Journal of the Association of Physicians
|
October 21, 2003
Intensified treatment of type 2 diabetes--positive effects on blood pressure, but not glycaemic control
G V Gill, A Woodward, S Pradhan, et al.
The Journal of Endocrinology
|
February 1, 1992
Increased neuropeptide Y content in individual hypothalamic nuclei, but not neuropeptide Y mRNA, in diet-induced obesity in rats
J P Wilding, S G Gilbey, M Mannan, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 154) with videos related to
Sort By:
Page
of 16
Pharmacogenomics and Personalized Medicine
|
March 17, 2021
Tackling Drug Resistance in EGFR Exon 20 Insertion Mutant Lung Cancer
Laura Pacini, Andrew D Jenks, Simon Vyse, et al.
Diabetes, Obesity & Metabolism
|
May 27, 2026
Randomised Controlled Feasibility Trial of Face-To-Face Diabetes Self-Management Education Shows High Completion Rates Are Needed to Improve Patient-Reported Outcomes
Gemma A Lewis, David M Hughes, Greg J Irving, et al.
Neuroendocrinology
|
April 1, 1993
Increases in neuropeptide Y content and gene expression in the hypothalamus of rats treated with dexamethasone are prevented by insulin
J P Wilding, S G Gilbey, P D Lambert, et al.
Journal of Neuroendocrinology
|
April 1, 1996
Reduced NPY induced feeding in diabetic but not steroid-treated rats: lack of evidence for changes in receptor number or affinity
D G Morgan, P D Lambert, D M Smith, et al.
Clinical Chemistry
|
November 9, 2000
Evaluation of DNA fragment sizing and quantification by the agilent 2100 bioanalyzer
N J Panaro, P K Yuen, T Sakazume, et al.
Brain Research
|
September 5, 1994
Effect of food deprivation and streptozotocin-induced diabetes on hypothalamic neuropeptide Y release as measured by a radioimmunoassay-linked microdialysis procedure
P D Lambert, J P Wilding, M D Turton, et al.
Brain Research
|
November 26, 1993
The effect of central blockade of kappa-opioid receptors on neuropeptide Y-induced feeding in the rat
P D Lambert, J P Wilding, A A al-Dokhayel, et al.
Journal of Diabetes and Its Complications
|
January 2, 2013
Active- and placebo-controlled dose-finding study to assess the efficacy, safety, and tolerability of multiple doses of ipragliflozin in patients with type 2 diabetes mellitus
Vivian A Fonseca, Ele Ferrannini, John P Wilding, et al.
QJM : Monthly Journal of the Association of Physicians
|
October 21, 2003
Intensified treatment of type 2 diabetes--positive effects on blood pressure, but not glycaemic control
G V Gill, A Woodward, S Pradhan, et al.
The Journal of Endocrinology
|
February 1, 1992
Increased neuropeptide Y content in individual hypothalamic nuclei, but not neuropeptide Y mRNA, in diet-induced obesity in rats
J P Wilding, S G Gilbey, M Mannan, et al.
Page
of 16